Parexel, a CRO providing the full range of Phase I to IV clinical development services, appointed Keri Mattox to the newly created role of Chief Business Officer. In this role Ms. Mattox will lead the company’s business operations and growth strategy. She brings more than 25 years of healthcare experience across corporate strategy and development, investor relations, communications and environmental, social and governance (ESG) programs. As part of the company’s senior leadership team, she will ...